Estimates Revisions Amplia Therapeutics Limited OTC Markets

Stocks

Delayed OTC Markets 12:54:21 23/09/2026 am IST			5-day change	1st Jan Change
0.0917 ^USD	+9.90%		+12.31%	+16.22%

15/09	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
04/08	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	WUXI APPTEC CO., LTD.
	ARGENX SE
	WUXI BIOLOGICS (CAYMAN) INC.
	INSMED INCORPORATED
	BIONTECH SE
	GENMAB A/S
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	PHARMAESSENTIA CORPORATION
	EXELIXIS, INC.
	Average
	Weighted average by Cap.